Bankruptcy

A court affirmed Avon must pay $51M for a woman's death from asbestos-laced talc, part of a wider legal storm engulfing the cosmetics industry.

A new lawsuit claims private equity giant TPG hid implant defects and forced a bankruptcy, leaving thousands of injured patients to pay the price.

A prime 11.2-acre development site in Carrollton, TX is up for auction, offering a rare chance to build a landmark project in the booming DFW market.

In a strategic pivot, Fresh Del Monte gets court approval to buy packaged food assets from its bankrupt namesake, aiming to unify the iconic brand.

After a second bankruptcy filing in five years, the 25-year-old fashion chain is closing for good, sparking huge sales and questions about its collapse.

A dramatic rise in commercial Chapter 11 filings signals an end to pandemic-era relief, as businesses and consumers face mounting economic headwinds.

Amid Chapter 11 liquidation, LiDAR firm Luminar sells off key assets to pay creditors, offering to buy back senior notes at a premium.

Amid financial scrutiny and following a major trial failure, Vistagen's upcoming Q3 update is a critical test for its novel pherine pipeline.

Once valued at $3.3B, the healthtech giant seeks Chapter 11 protection, a stark warning for the post-pandemic digital health industry.

Facing default, The Cannabist Company secures a short-term forbearance, highlighting a systemic liquidity crisis threatening the US cannabis industry.

Following a sudden Chapter 7 bankruptcy, the assets of a national trucking firm are now for sale, creating unique opportunities in a soft freight market.

Despite its Nobel Prize-winning technology, Danish water filtration firm Aquaporin has collapsed, highlighting the perilous 'valley of death' for deep tech.

Brazil's largest airline launches a crucial debt offering to exit Chapter 11, securing stable ratings from Moody's and Fitch in a major recovery milestone.

Anthology's restructuring concludes, creating a debt-free Blackboard and selling major assets to rivals Ellucian and Encoura in a major EdTech shake-up.

Swiss biotech GeNeuro suspends trading, awaiting a critical court ruling on its debt moratorium that will decide its fate and the future of its novel drugs.

After a failed reorganization, Stoli Group USA and Kentucky Owl enter Chapter 7 liquidation, a victim of Russian retaliation and a souring spirits market.

The wildly popular DTC supplement AG1 lands in 640+ Vitamin Shoppe stores. This landmark deal signals a major shift for wellness retail and consumer trust.

A new prop trading firm launches with an innovative model and a veteran leader. But Brian Ferdinand's recent personal bankruptcy adds a layer of risk.

In 2025, A&G saved retailers like Rite Aid and expanded its expertise to healthcare and life sciences, showcasing the power of strategic real estate.

As 10x Genomics preps for its J.P. Morgan spotlight, investors seek a clear path to profit amid fierce competition and groundbreaking innovation.